-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Actinogen Randomizes 247th Patient in Xanamia Phase 2b/3 Alzheimer’s Trial

Reuters·12/18/2025 13:33:16

Please log in to view news